Mckesson (MCK) Total Non-Current Liabilities (2009 - 2026)
Mckesson (MCK) posted quarterly Total Non-Current Liabilities of -$2.4 billion for Q1 2026, up 57.29% year-over-year from -$1.5 billion in Q1 2025, and down 102.91% quarter-over-quarter from $81.4 billion in Q4 2025.
Mckesson (MCK) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Mckesson (MCK) has reported Total Non-Current Liabilities for 17 consecutive years, with -$2.4 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 57.29% year-over-year to -$2.4 billion; the TTM figure through Mar 2026 stood at -$2.4 billion (up 57.29% YoY), while the FY2026 annual figure was -$2.4 billion, up 57.29% from the prior year.
- Total Non-Current Liabilities retreated to -$2.4 billion in Q1 2026 per MCK's latest filing, from $81.4 billion in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $81.4 billion in Q4 2025 and bottomed at -$6.1 billion in Q1 2024.
- Historically, Total Non-Current Liabilities has averaged $48.8 billion across 5 years, with a median of $60.2 billion in 2023.
- Annual changes were most pronounced in 2024 — Total Non-Current Liabilities slumped 245.0% — and 2026, when it surged 57.29%.
- Mckesson's Total Non-Current Liabilities stood at $56.0 billion in 2022, then climbed by 7.74% to $60.4 billion in 2023, then rose by 13.4% to $68.5 billion in 2024, then rose by 18.94% to $81.4 billion in 2025, then slumped by 102.91% to -$2.4 billion in 2026.
- Business Quant data shows MCK's Total Non-Current Liabilities at -$2.4 billion in Q1 2026, $81.4 billion in Q4 2025, and $81.4 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | 83.27 Bn |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | -2.92 Bn |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | - |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | 6.22 Bn |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | 2,565.00 |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | 75.80 Mn |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | 2.45 Bn |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | 251.86 Mn |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | 38.31 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 83.27 Bn |
| Mar 31, 2026 | -2.37 Bn |
| Dec 31, 2025 | 81.45 Bn |
| Sep 30, 2025 | 81.41 Bn |
| Jun 30, 2025 | 78.44 Bn |
| Mar 31, 2025 | -5.55 Bn |
| Dec 31, 2024 | 68.48 Bn |
| Sep 30, 2024 | 69.72 Bn |
| Jun 30, 2024 | 65.56 Bn |
| Mar 31, 2024 | -6.07 Bn |
| Dec 31, 2023 | 60.38 Bn |
| Sep 30, 2023 | 59.96 Bn |
| Jun 30, 2023 | 57.47 Bn |
| Mar 31, 2023 | -1.76 Bn |
| Dec 31, 2022 | 56.05 Bn |
| Sep 30, 2022 | 56.44 Bn |
| Jun 30, 2022 | 60.74 Bn |
| Dec 31, 2021 | 56.56 Bn |
| Sep 30, 2021 | 62.04 Bn |
| Jun 30, 2021 | 55.30 Bn |